Cytek Biosciences, Inc. CTKB Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableTradeCurrent.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s accounts payable?
- Cytek Biosciences, Inc. (CTKB) reported accounts payable of $6.74M in Q1 2026.
- How has Cytek Biosciences, Inc.'s accounts payable changed year-over-year?
- Cytek Biosciences, Inc.'s accounts payable increased by 7.9% year-over-year, from $6.25M to $6.74M.
- What is the long-term trend for Cytek Biosciences, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s accounts payable has grown at a 27.1% compound annual growth rate (CAGR), from $10.4M to $27.14M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.